169 related articles for article (PubMed ID: 24368422)
1. Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death.
Schmukler E; Wolfson E; Haklai R; Elad-Sfadia G; Kloog Y; Pinkas-Kramarski R
Oncotarget; 2014 Jan; 5(1):173-84. PubMed ID: 24368422
[TBL] [Abstract][Full Text] [Related]
2. Ras inhibition enhances autophagy, which partially protects cells from death.
Schmukler E; Grinboim E; Schokoroy S; Amir A; Wolfson E; Kloog Y; Pinkas-Kramarski R
Oncotarget; 2013 Jan; 4(1):145-55. PubMed ID: 23370967
[TBL] [Abstract][Full Text] [Related]
3. Continuous treatment with FTS confers resistance to apoptosis and affects autophagy.
Schmukler E; Wolfson E; Elazar Z; Kloog Y; Pinkas-Kramarski R
PLoS One; 2017; 12(2):e0171351. PubMed ID: 28151959
[TBL] [Abstract][Full Text] [Related]
4. Enhancing FTS (Salirasib) efficiency via combinatorial treatment.
Wolfson E; Schmukler E; Schokoroy ST; Kloog Y; Pinkas-Kramarski R
Biol Cell; 2015 May; 107(5):130-43. PubMed ID: 25735913
[TBL] [Abstract][Full Text] [Related]
5. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
Charette N; De Saeger C; Lannoy V; Horsmans Y; Leclercq I; Stärkel P
Mol Cancer; 2010 Sep; 9():256. PubMed ID: 20860815
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
Khwaja A; Sharpe CC; Noor M; Kloog Y; Hendry BM
Kidney Int; 2005 Aug; 68(2):474-86. PubMed ID: 16014024
[TBL] [Abstract][Full Text] [Related]
7. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
Gana-Weisz M; Halaschek-Wiener J; Jansen B; Elad G; Haklai R; Kloog Y
Clin Cancer Res; 2002 Feb; 8(2):555-65. PubMed ID: 11839677
[TBL] [Abstract][Full Text] [Related]
8. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
Erlich S; Tal-Or P; Liebling R; Blum R; Karunagaran D; Kloog Y; Pinkas-Kramarski R
Biochem Pharmacol; 2006 Aug; 72(4):427-36. PubMed ID: 16780807
[TBL] [Abstract][Full Text] [Related]
9. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
Zhao Y; Fan D; Ru B; Cheng KW; Hu S; Zhang J; Li ET; Wang M
Eur J Cancer; 2016 Nov; 68():38-50. PubMed ID: 27710830
[TBL] [Abstract][Full Text] [Related]
10. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis.
Blum R; Jacob-Hirsch J; Rechavi G; Kloog Y
Mol Cancer Ther; 2006 Sep; 5(9):2337-47. PubMed ID: 16985068
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and S-farnesylthiosalicylic acid have a synergistic effect on hepatic stellate cells proliferation.
Neeman R; Abramovitch S; Sharvit E; Elad-Sfadia G; Haklai R; Kloog Y; Reif S
Dig Dis Sci; 2014 Oct; 59(10):2462-9. PubMed ID: 24942325
[TBL] [Abstract][Full Text] [Related]
12. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
Guan Y; Zhang Y; Xiao L; Li J; Wang JP; Chordia MD; Liu ZQ; Chung LW; Yue W; Pan D
Mol Pharm; 2017 Jan; 14(1):1-13. PubMed ID: 26992462
[TBL] [Abstract][Full Text] [Related]
13. Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.
Faigenbaum R; Haklai R; Ben-Baruch G; Kloog Y
Oncotarget; 2013 Feb; 4(2):316-28. PubMed ID: 23530112
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells.
Du R; Sullivan DK; Azizian NG; Liu Y; Li Y
BMC Cancer; 2021 Mar; 21(1):237. PubMed ID: 33676427
[TBL] [Abstract][Full Text] [Related]
15. Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
Yue W; Wang J; Li Y; Fan P; Santen RJ
Int J Cancer; 2005 Dec; 117(5):746-54. PubMed ID: 15957161
[TBL] [Abstract][Full Text] [Related]
16. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
Stärkel P; Charette N; Borbath I; Schneider-Merck T; De Saeger C; Abarca J; Leclercq I; Horsmans Y
Mol Carcinog; 2012 Oct; 51(10):816-25. PubMed ID: 21882255
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
Barkan B; Kloog Y; Ehrlich M
Mol Cancer Ther; 2011 Aug; 10(8):1317-26. PubMed ID: 21632464
[TBL] [Abstract][Full Text] [Related]
18. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.
Haklai R; Elad-Sfadia G; Egozi Y; Kloog Y
Cancer Chemother Pharmacol; 2008 Jan; 61(1):89-96. PubMed ID: 17909812
[TBL] [Abstract][Full Text] [Related]
19. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
Santen RJ; Lynch AR; Neal LR; McPherson RA; Yue W
Anticancer Drugs; 2006 Jan; 17(1):33-40. PubMed ID: 16317288
[TBL] [Abstract][Full Text] [Related]
20. FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in mice.
Goldberg L; Israeli R; Kloog Y
Cell Death Dis; 2012 Mar; 3(3):e284. PubMed ID: 22419113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]